Sema Aydoğdu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sema Aydoğdu has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Ezgi Kıran Taşcı
Department of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, 35100 Izmir, Türkiye
5 shared publications - Miray Karakoyun
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Medical School of Ege University, Izmir, Turkey
5 shared publications - Eser Doğan
Ege University
3 shared publications - Funda Çetin
Ege Univ, Dept Pediat Gastroenterol, Div Hepatol & Nutr, Fac Med, Izmir, Turkey
3 shared publications - Ebru Canda
Ege University Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, İzmir, Turkey
2 shared publications - Ertürk Levent
Ege University, Faculty of Medicine, Pediatric Cardiology, 35100 Izmir, Turkey
2 shared publications
Latest Publications
- 1 September 2023
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 10 (3) , 167-172
Evaluation of Vascular Involvement in Children with Celiac Disease
- 1 September 2023
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 10 (3) , 167-172
Evaluation of Vascular Involvement in Children with Celiac Disease
- Open Access
- 15 March 2023
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 4 (1) , 14-18
Vascular involvement in pediatric inflammatory bowel disease
Objective: Patients with inflammatory bowel disease (IBD) have a higher incidence of cardiovascular disease (CVD). Early diagnosis of arterial damage is essential to prevent future vascular risk. We aimed to assess the vascular involvement IBD by monitoring inflammation parameters, echocardiography, augmentation index (AIx); carotid pulse wave velocity (PWV), carotid intima-media thickness (cIMT), and blood pressure. Method: The patient population included 25 subjects with a previously biopsy-proven diagnosis of IBD who had been on treatment for at least one year. Carotid PWV, AIx, and cIMT of the patients were measured. Results: Twenty-five patients (15 female and 10 male) with IBD and 25 healthy controls were included in this present study. There was a significant difference between the carotid PWV values (mean 4.84±0.39, 4.49±0.17, respectively, p <0.001), but no differences were observed in the cIMT and AIx values. Conclusion: The carotid PWV values assessing arterial stiffness may be effective, safe, and easy to detect subclinical atherosclerosis in children with IBD. Larger studies should be carried out to evaluate other indicators of early atherosclerosis and arterial stiffness such as cIMT and AIx.
- 15 March 2023
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 4 (1) , 14-18
Open AccessVascular involvement in pediatric inflammatory bowel disease
Objective: Patients with inflammatory bowel disease (IBD) have a higher incidence of cardiovascular disease (CVD). Early diagnosis of arterial damage is essential to prevent future vascular risk. We aimed to assess the vascular involvement IBD by monitoring inflammation parameters, echocardiography, augmentation index (AIx); carotid pulse wave velocity (PWV), carotid intima-media thickness (cIMT), and blood pressure. Method: The patient population included 25 subjects with a previously biopsy-proven diagnosis of IBD who had been on treatment for at least one year. Carotid PWV, AIx, and cIMT of the patients were measured. Results: Twenty-five patients (15 female and 10 male) with IBD and 25 healthy controls were included in this present study. There was a significant difference between the carotid PWV values (mean 4.84±0.39, 4.49±0.17, respectively, p <0.001), but no differences were observed in the cIMT and AIx values. Conclusion: The carotid PWV values assessing arterial stiffness may be effective, safe, and easy to detect subclinical atherosclerosis in children with IBD. Larger studies should be carried out to evaluate other indicators of early atherosclerosis and arterial stiffness such as cIMT and AIx.
- Open Access
- 3 March 2022
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 14 (1) , 1-9
Recommendations for Clinical Decision-making in Children with Type 1 Diabetes and Celiac Disease: Type 1 Diabetes and Celiac Disease Joint Working Group Report
It is well-known that in children with type 1 diabetes (T1D), the frequency of Celiac disease (CD) is increased due to mechanisms which are not fully elucidated but include autoimmune injury as well as shared genetic predisposition. Although histopathologic examination is the gold standard for diagnosis, avoiding unnecessary endoscopy is crucial. Therefore, for both clinicians and patients’ families, the diagnosis of CD remains challenging. In light of this, a joint working group, the Type 1 Diabetes and Celiac Disease Joint Working Group, was convened, with the aim of reporting institutional data and reviewing current international guidelines, in order to provide a framework for clinicians. Several controversial issues were discussed: For CD screening in children with T1D, regardless of age, it is recommended to measure tissue transglutaminase-immunoglobulin A (tTG-IgA) and/or endomysial-IgA antibody due to their high sensitivity and specificity. However, the decision-making process based on tTG-IgA titer in children with T1D is still debated, since tTG-IgA titers may fluctuate in children with T1D. Moreover, seronegativity may occur spontaneously. The authors’ own data showed that most of the cases who have biopsy-proven CD had tTG-IgA levels 7-10 times above the upper limit. The decision for endoscopy based solely on tTG-IgA levels should be avoided, except in cases where tTG-IgA levels are seven times and above the upper limit. A closer collaboration should be built between divisions of pediatric endocrinology and gastroenterology in terms of screening, diagnosis and follow-up of children with T1D and suspicious CD.
- 3 March 2022
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 14 (1) , 1-9
Open AccessRecommendations for Clinical Decision-making in Children with Type 1 Diabetes and Celiac Disease: Type 1 Diabetes and Celiac Disease Joint Working Group Report
It is well-known that in children with type 1 diabetes (T1D), the frequency of Celiac disease (CD) is increased due to mechanisms which are not fully elucidated but include autoimmune injury as well as shared genetic predisposition. Although histopathologic examination is the gold standard for diagnosis, avoiding unnecessary endoscopy is crucial. Therefore, for both clinicians and patients’ families, the diagnosis of CD remains challenging. In light of this, a joint working group, the Type 1 Diabetes and Celiac Disease Joint Working Group, was convened, with the aim of reporting institutional data and reviewing current international guidelines, in order to provide a framework for clinicians. Several controversial issues were discussed: For CD screening in children with T1D, regardless of age, it is recommended to measure tissue transglutaminase-immunoglobulin A (tTG-IgA) and/or endomysial-IgA antibody due to their high sensitivity and specificity. However, the decision-making process based on tTG-IgA titer in children with T1D is still debated, since tTG-IgA titers may fluctuate in children with T1D. Moreover, seronegativity may occur spontaneously. The authors’ own data showed that most of the cases who have biopsy-proven CD had tTG-IgA levels 7-10 times above the upper limit. The decision for endoscopy based solely on tTG-IgA levels should be avoided, except in cases where tTG-IgA levels are seven times and above the upper limit. A closer collaboration should be built between divisions of pediatric endocrinology and gastroenterology in terms of screening, diagnosis and follow-up of children with T1D and suspicious CD.
- 15 December 2020
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 2 (3) , 85-96
Consensus Statement on Provision of Appropriate Nutritional Support in the Management of Childhood Malnutrition: A Turkey Perspective
Pediatric malnutrition,consensus statement,diagnosis,nutritional support,enteral nutrition
- 15 December 2020
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 2 (3) , 85-96
Consensus Statement on Provision of Appropriate Nutritional Support in the Management of Childhood Malnutrition: A Turkey Perspective
Pediatric malnutrition,consensus statement,diagnosis,nutritional support,enteral nutrition
- Open Access
- 1 March 2020
- Published by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 23 (2) , 146-153
Liver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study
Purpose: Alpha-1 antitrypsin deficiency (A1ATD) in one of the most common genetic causes of liver disease in children. We aimed to analyze the clinical characteristics and outcomes of patients with A1ATD. Methods: This study included patients with A1ATD from five pediatric hepatology units. Demographics, clinical findings, genetics, and outcome of the patients were recorded (n=25). Results: Eight patients (32.0%) had homozygous PiZZ genotype while 17 (68.0%) had heterozygous genotype. Patients with PiZZ genotype had lower alpha-1 antitrypsin levels than patients with PiMZ genotype (37.6 +/- 7.7 mg/dL vs. 66.5 +/- 22.7 mg/dL, p=0.0001). Patients with PiZZ genotype were diagnosed earlier than patients with PiMZ genotype, but this was not significant (13 +/- 6.8 months vs. 23.7 +/- 30.1 months, p=0.192). Follow-up revealed the death of one patient (12.5%) with a homozygous mutation, and revealed that one patient had child A cirrhosis, five patients (62.5%) had chronic hepatitis, and one patient (12.5%) was asymptomatic. Nine of the 17 patients with a heterozygous mutation had chronic hepatitis (52.9%), two (11.7%) had child A cirrhosis, and six (35.2%) were asymptomatic. Overall, 18 (72%) of the 25 children had liver pathology in the long-term. Conclusion: Although prevalence is rare, patients with liver disorders should be checked for alpha-1 antitrypsin levels. Moreover, long-term follow-up is essential because most patients have a liver pathology.
- 1 March 2020
- Published by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 23 (2) , 146-153
Open AccessLiver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study
Purpose: Alpha-1 antitrypsin deficiency (A1ATD) in one of the most common genetic causes of liver disease in children. We aimed to analyze the clinical characteristics and outcomes of patients with A1ATD. Methods: This study included patients with A1ATD from five pediatric hepatology units. Demographics, clinical findings, genetics, and outcome of the patients were recorded (n=25). Results: Eight patients (32.0%) had homozygous PiZZ genotype while 17 (68.0%) had heterozygous genotype. Patients with PiZZ genotype had lower alpha-1 antitrypsin levels than patients with PiMZ genotype (37.6 +/- 7.7 mg/dL vs. 66.5 +/- 22.7 mg/dL, p=0.0001). Patients with PiZZ genotype were diagnosed earlier than patients with PiMZ genotype, but this was not significant (13 +/- 6.8 months vs. 23.7 +/- 30.1 months, p=0.192). Follow-up revealed the death of one patient (12.5%) with a homozygous mutation, and revealed that one patient had child A cirrhosis, five patients (62.5%) had chronic hepatitis, and one patient (12.5%) was asymptomatic. Nine of the 17 patients with a heterozygous mutation had chronic hepatitis (52.9%), two (11.7%) had child A cirrhosis, and six (35.2%) were asymptomatic. Overall, 18 (72%) of the 25 children had liver pathology in the long-term. Conclusion: Although prevalence is rare, patients with liver disorders should be checked for alpha-1 antitrypsin levels. Moreover, long-term follow-up is essential because most patients have a liver pathology.
- 16 October 2019
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 6 (3) , 208-212
Determination of Variables Influencing the Quality of Life in Children with Liver Transplantation
- 16 October 2019
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 6 (3) , 208-212
Determination of Variables Influencing the Quality of Life in Children with Liver Transplantation
- 11 July 2019
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 6 (2) , 115-120
Pediatric Liver Transplantation Outcomes for Metabolic and Non-metabolic Diseases in Turkey: A Single Center Experience
- 11 July 2019
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 6 (2) , 115-120
Pediatric Liver Transplantation Outcomes for Metabolic and Non-metabolic Diseases in Turkey: A Single Center Experience
- 26 April 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32 (5) , 533-536
Two siblings with Gaucher type 3c: different clinical presentations
Background: Gaucher disease (GD) is a lysosomal storage disorder caused by autosomal recessive mutations in the glucocerebrosidase (GBA) gene, which encodes acid β-glucosidase. GD type 3c is a rare group characterised by cardiovascular involvement, and homozygous D448H is the most frequent mutation. Case presentation: We describe two patients who had homozygous D448H mutations. The index patient had hepatosplenomegaly, liver insufficiency and cardiac involvement and her sister had severe cardiac involvement with cardiomyopathy and diffuse aortic calcification. The index case’s liver was transplanted at the age of 6 months from a related donor and her sister who had severe cardiovascular disease died at the age of 12 years. Conclusions: Our patients had clinical variability. We need to discuss whether liver involvement could be the initial signs in patients with GD type 3c.
- 26 April 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32 (5) , 533-536
Two siblings with Gaucher type 3c: different clinical presentations
Background: Gaucher disease (GD) is a lysosomal storage disorder caused by autosomal recessive mutations in the glucocerebrosidase (GBA) gene, which encodes acid β-glucosidase. GD type 3c is a rare group characterised by cardiovascular involvement, and homozygous D448H is the most frequent mutation. Case presentation: We describe two patients who had homozygous D448H mutations. The index patient had hepatosplenomegaly, liver insufficiency and cardiac involvement and her sister had severe cardiac involvement with cardiomyopathy and diffuse aortic calcification. The index case’s liver was transplanted at the age of 6 months from a related donor and her sister who had severe cardiovascular disease died at the age of 12 years. Conclusions: Our patients had clinical variability. We need to discuss whether liver involvement could be the initial signs in patients with GD type 3c.
- 15 November 2018
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 29 (6) , 664-668
Results of 1001 liver transplantations in 23 years: Ege University experience
Background/Aims: Liver transplantation (LT) is now the standard of care for most end-stage liver diseases. Over the next 30 years, advances in medicine and technology will greatly improve the survival rates of patients after this procedure. The aim of the present study was to analyze retrospectively the results of 1001 patients withLT. Materials and Methods: Medical reports of 989 patients were analyzed retrospectively. Data were obtained from the patient’s data chart. Descriptive statistics were used to describe continuous variables (mean, median, and standard deviation). Results: A total of 1001 LTs for 989 recipients were performed at Ege University Organ Transplantation and Research Center between 1994 and 2017. Therewere 639 male and 350 female recipients. Among 1001 LTs, there were 438 deceased donors and 563 living donors. The age interval of the patients was 4 months to 71 years old. The median Model for End-Stage Liver Disease score was 20. There were 12 deceased liver donors using the split method. There were 12 cases subject to retransplantation. In living donor LT grafts, 423 right lobes, 46 left lobes, and 94 left lateral sectors were used. In the first monitoring,the total annual mortality rate was 130 cases (13%). The mortality rate in retransplantation was found to be 66%. A 1-year survival rate of 87% was generally established. Conclusion: LThas been improving consistently over the last two decades. Ege University is one of the biggest liver transplant centers in Turkey for both technical and educational perspective. Cite this article as: Zeytunlu M, Uğuz A, Ünalp Ö, et al. Results of 1001 liver transplantations in 23 years: Ege University experience. Turk J Gastroenterol 2018; 29: 664-8.
- 15 November 2018
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 29 (6) , 664-668
Results of 1001 liver transplantations in 23 years: Ege University experience
Background/Aims: Liver transplantation (LT) is now the standard of care for most end-stage liver diseases. Over the next 30 years, advances in medicine and technology will greatly improve the survival rates of patients after this procedure. The aim of the present study was to analyze retrospectively the results of 1001 patients withLT. Materials and Methods: Medical reports of 989 patients were analyzed retrospectively. Data were obtained from the patient’s data chart. Descriptive statistics were used to describe continuous variables (mean, median, and standard deviation). Results: A total of 1001 LTs for 989 recipients were performed at Ege University Organ Transplantation and Research Center between 1994 and 2017. Therewere 639 male and 350 female recipients. Among 1001 LTs, there were 438 deceased donors and 563 living donors. The age interval of the patients was 4 months to 71 years old. The median Model for End-Stage Liver Disease score was 20. There were 12 deceased liver donors using the split method. There were 12 cases subject to retransplantation. In living donor LT grafts, 423 right lobes, 46 left lobes, and 94 left lateral sectors were used. In the first monitoring,the total annual mortality rate was 130 cases (13%). The mortality rate in retransplantation was found to be 66%. A 1-year survival rate of 87% was generally established. Conclusion: LThas been improving consistently over the last two decades. Ege University is one of the biggest liver transplant centers in Turkey for both technical and educational perspective. Cite this article as: Zeytunlu M, Uğuz A, Ünalp Ö, et al. Results of 1001 liver transplantations in 23 years: Ege University experience. Turk J Gastroenterol 2018; 29: 664-8.